Commit To Buy Biogen Idec At $230, Earn 5.2% Using Options
July 28, 2014 at 11:23 AM EDT
Investors eyeing a purchase of Biogen Idec Inc (BIIB) stock, but tentative about paying the going market price of $332.79/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2016 put at the $230 strike, which has a bid at the time of this writing of $12.00..